Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25161 | EP6 | 1353567-32-4 | 98% Min. |  |
| EP6 is a 5-lipoxygenase (5-LO) inhibitor. 5-LO is a crucial enzyme of the arachidonic | ||||
| 25160 | Elzovantinib | 2271119-26-5 | 98% Min. |  |
| Elzovantinib, also known as TPX-0022 and CSF1R-IN-2, is an orally bioavailable CSF1R | ||||
| 25141 | Etavopivat | 2245053-57-8 | 98% Min. |  |
| Etavopivat, also known as FT-4202, is a pyruvate kinase activator. Etavopivat decreas | ||||
| 25123 | Etripamil | 1593673-23-4 | 98% Min. |  |
| Etripamil is a calcium channel blocker. Calcium channel blockers (CCB), calcium chann | ||||
| 25086 | E-7386 | 1799824-08-0 | 98% Min. |  |
| E-7386 is an orally active CBP/beta-catenin modulator. | ||||
| 25069 | Emavusertib | 1801344-14-8 | 98% Min. |  |
| Emavusertib, also known as CA-4948 is a potent IRAK4/FLT3 inhibitor with anti-tumor a | ||||
| 25065 | Ecopipam ( SCH 39166 ) | 112108-01-7 | ≧98.0% | _112108-01-7.png) |
| Ecopipam ( SCH 39166 ) is a Selective Dopamine Receptor D1/D5 Antagonist used in the | ||||
| 24118 | Emraclidine | 2170722-84-4 | 98% Min. |  |
| Emraclidine, also known as CVL-231 and PF-06852231, is a novel, brain-penetrant, high | ||||
| 24075 | EG-2184 | 2770297-66-8 | 98% Min. |  |
| 24055 | E7046 | 1369489-71-3 | 98% Min. |  |
| E7046 is a potent and selective antagonist of the type 4 prostaglandin E2 (PGE2) rece | ||||
| 24032 | EPZ-719 | 2697176-16-0 | 98% Min. |  |
| 20635 | ERAS-801 ( JGK-068S ) | 2490431-16-6 | ≧98.0% |  |
| ERAS-801 ( JGK-068S ) is a potent EGFR inhibitor. | ||||
| 20636 | Edecesertib ( GS-5718 ) | 2408839-73-4 | ≧98.0% | _2408839-73-4.png) |
| GS-5718 (Edecesertib) is a potent, selective, orally bioavailable IRAK4 inhibitor. | ||||
| 20607 | Ezurpimtrostat HCl | 1914148-73-4 | 98% Min. |  |
| Ezurpimtrostat is a palmitoyl protein thioesterase 1 (PPT-1) inhibitor. | ||||
| 20603 | EN460 | 496807-64-8 | 98% Min. |  |
| EN460 is an endoplasmic reticulum oxidoreductase (ERO1) inhibitor. EN460 showed a dos | ||||
| 20546 | (E)-4-Morpholinobut-2-enoic acid hydrochloride | 1419865-05-6 | 98% Min. | -4-Morpholinobut-2-enoic_acid_hydrochloride_1419865-05-6.png) |
| 20523 | 1-ETHYL-1H-PYRAZOLE-4-CARBALDEHYDE | 304903-10-4 | 98% Min. |  |
| 20480 | ethyl 5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine-3-carboxylate | 2359650-50-1 | ≧96.0% |  |
| 20449 | Ervogastat (PF-06865571) | 2186700-33-2 | ≧98.0% |  |
| Ervogastat (PF-06865571), a systemically acting diacylglycerol acyltransferase (DGAT2 | ||||
| 20447 | ELQ300 | 1354745-52-0 | 98% Min. |  |
| ELQ300 is a novel inhibitor of the mitochondrial cytochrome bc1 complex (complex III | ||||
| 20443 | Etrumadenant | 2239273- 34-6 | 98% Min. |  |
| Etrumadenant, also known as AB928, is a dual antagonist of the A2aR and A2bR adenosin | ||||
| 20436 | E6446 | 1219925-73-1 | 98% Min. |  |
| E6446 is a TLR inhibitor. E6446 inhibits Toll-like receptor (TLR)7 and 9 signaling. E | ||||
| 171455 | Etrumadenant | 2239273-34-6 | 98% Min. |  |
| Etrumadenant, also known as AB928, is a dual antagonist of the A2aR and A2bR adenosin | ||||
| 171652 | EZM0414 | 2411748-50-8 | ≧98.0% |  |
| EZM0414 is a potent, selective, and orally bioavailable inhibitor of SETD2. | ||||
| 20390 | ethyl 4,6-dihydroxypyridazine-3-carboxylate | 1352925-63-3 | 98% Min. |  |
| G20384 | 5-(Ethoxycarbonyl)-2-formyl-4-methyl-1H-pyrrole-3-propanoic Acid Methyl Ester | 54278-05-6 | 98% Min. | -2-formyl-4-methyl-1H-pyrrole-3-propanoic_Acid_Methyl_Ester_54278-05-6.png) |
| 20366 | Ethyl 3-formyl-4-hydroxybenzoate | 82304-99-2 | 98% Min. |  |
| 20365 | ethyl 3-bromo-4-ethoxy-5-formylbenzoate | 2701520-23-0 | 98% Min. |  |
| 20360 | ethyl 4-hydroxy-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate | 1443978-76-4 | 98% Min. |  |
| 20359 | ethyl 4-chloro-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate | 1449598-75-7 | 98% Min. |  |